Vitamin D deficiency is associated with increased left ventricular mass and diastolic dysfunction in children with chronic kidney disease

Pediatric Cardiology

Volumn 34, Issue 3, 2013, Pages 536-542

  Patange, Amit R ^a   Valentini, Rudolph P ^a   Gothe, Mayuri P ^a   Du, Wei ^a   Pettersen, Michael D ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

CKD; Diastolic dysfunction; Left ventricular mass; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PARATHYROID HORMONE; PHOSPHORUS;

ADOLESCENT; ADULT; ARTERIAL STIFFNESS; ARTICLE; AUGMENTATION INDEX; BLOOD PRESSURE MEASUREMENT; CALCIUM BLOOD LEVEL; CALCIUM METABOLISM; CARDIOVASCULAR FUNCTION; CHILD; CHILDHOOD DISEASE; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIASTOLIC DYSFUNCTION; DISEASE ASSOCIATION; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; GLOMERULUS FILTRATION RATE; HEART LEFT VENTRICLE MASS; HEART PERFORMANCE; HOSPITALIZED CHILD; HUMAN; HYPERTENSION; MALE; MASS; PARATHYROID HORMONE BLOOD LEVEL; PERITONEAL DIALYSIS; PHOSPHATE BLOOD LEVEL; PHOSPHATE METABOLISM; RADIAL ARTERY; SCHOOL CHILD; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HYPERTENSION; TONOMETRY; TWO DIMENSIONAL ECHOCARDIOGRAPHY; UREA NITROGEN BLOOD LEVEL; VITAMIN D DEFICIENCY;

ADOLESCENT; AGE DISTRIBUTION; ANALYSIS OF VARIANCE; CHILD; COMORBIDITY; CROSS-SECTIONAL STUDIES; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE, DIASTOLIC; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; INCIDENCE; MALE; MULTIVARIATE ANALYSIS; PROGNOSIS; REGRESSION ANALYSIS; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SURVIVAL ANALYSIS; VITAMIN D DEFICIENCY;

EID: 84879506393     PISSN: 01720643     EISSN: 14321971     Source Type: Journal    
DOI: 10.1007/s00246-012-0489-z     Document Type: Article

References (41)

1. Amann K, Ritz E, Wiest G, Klaus G, Mall G (1994) A role of parathyroid hormone for the activation of cardiac fibroblasts in uremia. J Am Soc Nephrol 4:1814-1819
2. Artaza JN, Mehrotra R, Norris KC (2009) Vitamin D and the cardiovascular system. Clin J Am Soc Nephrol 4:1515-1522
3. Chinali M, de Simone G, Matteucci MC, Picca S, Mastrostefano A, Anarat A, Caliskan S, Jeck N, Neuhaus TJ, Peco-Antic A, Peruzzi L, Testa S, Mehls O, Wühl E, Schaefer F, ESCAPE Trial Group (2007) Reduced systolic myocardial function in children with chronic renal insufficiency. J Am Soc Nephrol 18:593-598
4. De Simone G, Daniels SR, Devreux RB et al (1992) Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. J Am Coll Cardiol 20:1251-1260
5. Devreux RB, Reichec N (1977) Echocardiographic determination of left ventricular mass in man: anatomic validation of the method. Circulation 55:613-618
6. Haciomeroglu P, Ozkaya O, Gunal N, Baysal K (2008) An echocardiographic assessment of cardiac functions and structure in children on dialysis. Ren Fail 30:147-153
7. Issa LL, Leong GM, Sutherland RL et al (2002) Vitamin D analogue-specific recruitment of vitamin D receptor coactivators. J Bone Miner Res 17:879-890
8. Kong J, Kim GH, Wei M, Sun T, Li G, Liu SQ, Li X, Bhan I, Zhao Q, Thadhani R, Li YC (2010) Therapeutic effects of vitamin D analogs on cardiac hypertrophy in spontaneously hypertensive rats. Am J Pathol 177:622-631
9. Levin A, Bakris GL, Molitch M et al (2007) Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int 71:31-38
10. Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP (2002) 1,25- Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 110:229-238
11. London GM, Pannier B, Guerin AP et al (2001) Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis: follow-up of an interventional study. J Am Soc Nephrol 12:2759-2767
12. Mancuso P, Rahman A, Hershey SD, Dandu L, Nibbelink KA, Simpson RU (2008) 1,25-Dihydroxyvitamin-D3 treatment reduces cardiac hypertrophy and left ventricular diameter in spontaneously hypertensive heart failure-prone (cp/+) rats independent of changes in serum leptin. J Cardiovasc Pharmacol 51:559-564
13. Massry SG (1984) Parathyroid hormone and uremic myocardiopathy. Contrib Nephrol 41:231-239
14. Massry SG, Smogorzewski M (1995) The mechanisms responsible for the PTH-induced rise in cytosolic calcium in various cells are not uniform. Miner Electrolyte Metab 21:13-28
15. Matias PJ, Jorge C, Ferreira C, Borges M, Aires I, Amaral T, Gil C, Cortez J, Ferreira A (2010) Cholecalciferol supplementation in hemodialysis patients: effects on mineral metabolism, inflammation, and cardiac dimension parameters. Clin J Am Soc Nephrol 5:905-911
16. Mitsnefes MM, Kimball TR, Border WL, Witt SA, Glascock BJ, Khoury PR, Daniels SR (2004) Impaired left ventricular diastolic function in children with chronic renal failure. Kidney Int 65:1461-1466
17. Mitsnefes MM, Kimball TR, Kartal J, Witt SA, Glascock BJ, Khoury PR, Daniels SRJ (2005) Cardiac and vascular adaptation in pediatric patients with chronic kidney disease: role of calcium-phosphorus metabolism. Am Soc Nephrol 16:2796-2803
18. Mitsnefes MM, Kimball TR, Kartal J, Witt SA, Glascock BJ, Khoury PR, Daniels SR (2006) Progression of left ventricular hypertrophy in children with early chronic kidney disease: 2-year follow-up study. J Pediatr 149:671-675
19. Mitsnefes M, Flynn J, Cohn S, Samuels J, Blydt-Hansen T, Saland J, Kimball T, Furth S, Warady B, CKiD Study Group (2010) Masked hypertension associates with left ventricular hypertrophy in children with CKD. J Am Soc Nephrol 21:137-144
20. NAPRTCS (2005) The NAPRTCS 2005 annual report. Available at https://web.emmes.com/study/ped/annlrept/annlrept2005.pdf. Accessed 12 Mar 2012
21. 2-vitamin D3 actions on cell proliferation, size, gene expression, and receptor localization in the HL-1 cardiac myocyte. J Steroid Biochem Mol Biol 103:533-537
22. O'Connell TD, Berry JE, Jarvis AK, Somerman MJ, Simpson RU (1997) 1,25-Dihydroxyvitamin D3 regulation of cardiac myocyte proliferation and hypertrophy. Am J Physiol 272(4 Pt 2): H1751-H1758
23. Parekh RS, Carroll CE, Wolfe RA, Port FK (2002) Cardiovascular mortality in children and young adults with end-stage kidney disease. J Pediatrics 141:191-197
24. Patange AR, Valentini RP, Du W, Pettersen MD (2012) Vitamin D deficiency and arterial wall stiffness in children with chronic kidney disease. Pediatr Cardiol 33:122-128
25. Rinat C, Becker-Cohen R, Nir A, Feinstein S, Shemesh D, Algur N, Ben Shalom E, Farber B, Frishberg Y (2010) A comprehensive study of cardiovascular risk factors, cardiac function, and vascular disease in children with chronic renal failure. Nephrol Dial Transplant 25:785-793
26. Rostand SG, Drüeke TB (1999) Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure. Kidney Int 56:383-392
27. Rostand SG, Sanders C, Kirk KA, Rutsky EA, Fraser RG (1988) Myocardial calcification and cardiac dysfunction in chronic renal failure. Am J Med 85:651-657
28. Schwartz GJ, Haycock GB, Edelmann CM Jr, Spitzer A (1976) A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 58:259-263
29. Smogorzewski M (1995) Miner electrolyte: PTH, chronic renal failure, and myocardium. Metabolism 21:55-62
30. Takeyama K-I, Masuhiro Y, Fuse H et al (1999) Selective interaction of vitamin D receptor with transcriptional coactivators by a vitamin D analog. Mol Cell Biol 19:1049-1055
31. Tan X, Li YC, Liu Y (2006) Paricalcitol and cardiac structure and function in animals and humans (abstract no. TH-FC155). J Am Soc Nephrol 17: 21A
32. Tei C, Ling LH, Hodge DO (1995) New index combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function: a study in normal and dilated cardiomyopathy. J Cardiol 26:357-366
33. Teng M, Wolf M, Ofsthun MN et al (2005) Activated injectable vitamin D and hemodialysis survival: a historical cohort study. J Am Soc Nephrol 16:1115-1125
34. Terman DS, Alfrey AC, Hammond WS, Donndelinger T, Ogden DA, Holmes JH (1971) Cardiac calcification in uremia: a clinical, biochemical, and pathologic study. Am J Med 50:744-755
35. Weaver DJ Jr, Kimball T, Witt SA, Glascock BJ, Khoury PR, Kartal J, Mitsnefes MM (2008) Subclinical systolic dysfunction in pediatric patients with chronic kidney disease. J Pediatr 153:565-569
36. Weaver DJ Jr, Kimball TR, Knilans T, Mays W, Knecht SK, Gerdes YM, Witt S, Glascock BJ, Kartal J, Khoury P, Mitsnefes MM (2008) Decreased maximal aerobic capacity in pediatric chronic kidney disease. J Am Soc Nephrol 19:624-630
37. Wilson AC, Mitsnefes MM (2009) Cardiovascular disease in CKD in children: update on risk factors, risk assessment, and management. Am J Kidney Dis 54:345-360
38. 2-vitamin D3 and retinoic acid antagonize endothelin-stimulated hypertrophy of neonatal rat cardiac myocytes. J Clin Invest 97:1577-1588
39. Wu-Wong JR, Nakane M, Traylor L et al (2005) Cardiovascular disease in chronic kidney failure: is there a role for vitamin D analogs. Curr Opin Invest Drug 6:245-254
40. Wu-Wong JR, Nakane M, Ma J et al (2006) Effects of vitamin D analogs on gene expression profiling in human coronary artery smooth muscle cells. Atherosclerosis 186:20-28
41. Zhao G, Simpson RU (2010) Interaction between vitamin D receptor with caveolin-3 and regulation by 1,25-dihydroxyvitamin D3 in adult rat cardiomyocytes. J Steroid Chem Mol Biol 121:159-163